Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A systematic comparison of two new releases of exome sequencing products: the aim of use determines the choice of product.

Biological chemistry - 1 Aug 2016

Altmüller Janine, Motameny Susanne, Becker Christian, Thiele Holger, Chatterjee Sreyoshi, Wollnik Bernd, Nürnberg Peter

Abstract excerpt

We received early access to the newest releases of exome sequencing products, namely Agilent SureSelect v6 (Agilent, Santa Clara, CA, USA) and NimbleGen MedExome (Roche NimbleGen, Basel, Switzerland), and we conducted whole exome sequencing (WES) of several DNA samples with each of these products in order to assess their performance. Here, we provide a detailed evaluation of the original, normalized (with respect...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Source

Identifiers

PMID: 27021259
DOI: 10.1515/hsz-2015-0300

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A systematic comparison of two new releases of exome sequencing products: the aim of use determines the choice of product.PMID 27021259Read ↗

Comparison of Mendeliome exome capture kits for use in clinical diagnostics.Semantic proximity Read ↗

Performance comparison of four commercial human whole-exome capture platforms.Semantic proximity Read ↗

New insights into the performance of human whole-exome capture platforms.Semantic proximity Read ↗

ExomeSlicer: a resource for the development and validation of exome-based clinical panelsSemantic proximity Read ↗

The Rise and Rise of Exome Sequencing.Semantic proximity Read ↗

Recommendations for whole genome sequencing in diagnostics for rare diseases.Semantic proximity Read ↗

Comparative evaluation of four exome enrichment solutions in 2024: Agilent, Roche, Vazyme and NanodigmbioSemantic proximity Read ↗

Utility of Whole-Exome Sequencing in Pediatric and Medical DiagnosisSemantic proximity Read ↗

Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variantsSemantic proximity Read ↗

Comprehensive comparison of three commercial human whole-exome capture platforms.Semantic proximity Read ↗

Comparative evaluation of four exome enrichment solutions in 2024: Agilent, Roche, Vazyme and NanodigmbioSemantic proximity Read ↗

Performance comparison: exome-sequencing as a single test replacing Sanger-sequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.